{"id":"NCT01437540","sponsor":"AstraZeneca","briefTitle":"Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease","officialTitle":"A Long-Term, Randomized, Study of the Safety and Tolerability of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-19","primaryCompletion":"2013-03-31","completion":"2013-04-30","firstPosted":"2011-09-21","resultsPosted":"2017-05-11","lastUpdate":"2017-05-11"},"enrollment":590,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Aclidinium Bromide/Formoterol Fumarate","otherNames":[]},{"type":"DRUG","name":"Formoterol Fumarate","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the long-term safety and tolerability of inhaled aclidinium bromide/formoterol in patients with moderate to severe, stable chronic obstructive pulmonary disease (COPD).","primaryOutcome":{"measure":"Percentage of Patients to Experience at Least One Treatment-emergent Adverse Event (TEAE)","timeFrame":"Up to study Week 56 ± 3 days","effectByArm":[{"arm":"Aclidinium/Formoterol 400 μg/12 μg","deltaMin":71.4,"sd":null},{"arm":"Formoterol 12 μg","deltaMin":65.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":10},"locations":{"siteCount":137,"countries":["United States"]},"refs":{"pmids":["27296819"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4061&filename=lac-md-32-synopsis.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":392},"commonTop":["Chronic obstructive pulmonary disease","Urinary tract infection","Nasopharyngitis","Sinusitis","Upper respiratory tract infection"]}}